Key facts

Active Substance
Aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergic extract of equal amounts of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis pollen (Grasses-Mix) and Secale cereale (cultivated rye) pollen (50/50)
Therapeutic area
Pneumology-allergology
Decision number
P/0392/2017
PIP number
EMEA-000792-PIP01-09-M01
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
  • Treatment of allergic rhinitis
  • Treatment of rhino-conjuctivitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries

LETI Pharma GmbH

Tel. +49 89121400290
E-mail: paediatrics@leti.de

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

P/0392/2017: EMA decision of 19 December 2017 on the acceptance of a modification of an agreed paediatric investigation plan for aluminium hydroxide adsorbed, depigmented glutaraldehyde polymerised, allergic extract of ...

How useful do you find this page?